Cervical Dysplasia and High-Risk Human Papillomavirus Infections among HIV-Infected and HIV-Uninfected Adolescent Females in South Africa

Table 2

Epidemiology of HPV by HIV status.

	HIV-infected; Frequency (%)	HIV-uninfected; Frequency (%)	value
Any HPV	31 (88.6)	24 (48.0)	<0.001
Any LR-HPV	29 (82.9)	17 (34.0)	<0.001
Any HR-HPV	21 (60.0)	12 (24.0)	0.001
Vaccine HR-HPV
HPV 16	7 (20.0)	3 (6.0)	0.049
HPV 18	5 (14.3)	2 (4.0)	0.090
HPV 16 and/or 18	11 (31.4)	5 (10.0)	0.013
HPV 16 and/or 18 only (non-vaccine HR-HPV not present)	3 (8.6)	1 (2.0)	0.375
Non-vaccine HR-HPV
HPV 31	1 (2.9)	0 (0.0)	0.229
HPV 33	1 (2.9)	0 (0.0)	0.229
HPV 35	5 (14.3)	1 (2.0)	0.030
HPV 39	2 (5.7)	2 (4.0)	0.713
HPV 45	9 (25.7)	0 (0.0)	<0.001
HPV 51	3 (8.6)	3 (6.0)	0.649
HPV 52	4 (11.4)	2 (4.0)	0.188
HPV 56	2 (5.7)	0 (0.0)	0.087
HPV 58	1 (2.9)	1 (2.0)	0.798
HPV 59	1 (2.9)	1 (2.0)	0.798
HPV 68	7 (20.0)	3 (6.0)	0.049
Any non-vaccine HR-HPV	18 (51.4)	11 (22.0)	0.005
Non-vaccine HR-HPV only (HPV 16 and 18 not present)	10 (28.6)	7 (14.0)	0.098
Multiple concurrent HPV	24 (68.6)	11 (22.0)	<0.001
Multiple concurrent HR-HPV	15 (42.9)	6 (12.0)	0.001